SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-024126
Filing Date
2022-06-24
Accepted
2022-06-24 08:33:39
Documents
12
Period of Report
2022-06-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20220622.htm   iXBRL 8-K 34095
  Complete submission text file 0001564590-22-024126.txt   158815

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acor-20220622.xsd EX-101.SCH 5581
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20220622_lab.xml EX-101.LAB 18591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20220622_pre.xml EX-101.PRE 11031
6 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20220622_htm.xml XML 3431
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 221037089
SIC: 2836 Biological Products, (No Diagnostic Substances)